[PDF] Top 20 Cuidados de enfermería para un trabajo de parto humanizado
Has 10000 "Cuidados de enfermería para un trabajo de parto humanizado" found on our website. Below are the top 20 most common "Cuidados de enfermería para un trabajo de parto humanizado".
Azithromycin in DuraSite<sup>®</sup> for the treatment of blepharitis
... of azithromycin, which can be achieved in ocular surface tissues, particularly eyelids, after topical administration when combined with the DuraSite delivery vehicle, and the degree to which these levels ... See full document
26
Update and critical appraisal of the use of topical azithromycin ophthalmic 1% (AzaSite<sup>®</sup>) solution in the treatment of ocular infections
... the azithromycin ophthalmic solution, 1% was reported to be well ...with blepharitis was eye irritation, which occurred in approximately 1%–2% of ... See full document
9
Effectiveness, tolerability and safety of azithromycin 1% in DuraSite<sup>®</sup> for acute bacterial conjunctivitis
... Although the study states that it was randomized there is no explanation of sequence gen- eration or alloca- tion concealment during enrolment. Patients could not have been blinded to their treatment as the ... See full document
5
Clinical development of 1% azithromycin in DuraSite<sup>®</sup>, a topical azalide anti-infective for ocular surface therapy
... overall treatment burden and encourage patient compliance. Azithromycin is a well known systemic anti-infective with broad spectrum activity against gram positive-, gram negative-, and atypical bacteria ... See full document
19
Patients’ perspectives and preferences in the choice of inhalers: the case for Respimat<sup>® </sup>or HandiHaler<sup>®</sup>
... drug treatment and inhaler device remains ...the treatment deci- sion is becoming increasingly recognized, 2,9,12–14 and this article proposes that careful ... See full document
34
<p>Efficacy and safety of tiotropium + olodaterol maintenance treatment in patients with COPD in the TONADO<sup>®</sup> and OTEMTO<sup>®</sup> studies: a subgroup analysis by age</p>
... Primary end points, measured at 12 weeks (OTEMTO) or 24 weeks (TONADO), included St George’s Respiratory Questionnaire (SGRQ) total score, forced expiratory volume in 1 second (FEV 1 ) area under the curve from 0 hour to ... See full document
9
<p>An integrated safety analysis of combined acetaminophen and ibuprofen (Maxigesic<sup>®</sup>/ Combogesic<sup>®</sup>) in adults</p>
... (Table 1). Exclusion criteria included patients unable/unwill- ing to provide consent, women of childbearing potential, recent NSAID, APAP, or opioid use, and contraindications to IBP or APAP. Double-blinding was ... See full document
7
Tiotropium HandiHaler<sup>® </sup>and Respimat<sup>®</sup> in COPD: a pooled safety analysis
... Pooling clinical data into meta-analyses includes such limi- tations as differences in trial populations, trial design, and phy- sician diagnostic reporting. However, the present safety review reduced these limitations ... See full document
52
Baracle<sup>®</sup> vs Baraclude<sup>®</sup> for 48 weeks in patients with treatment-naïve chronic hepatitis B: a comparison of efficacy and safety
... with ETV from Dong-A ST and with ETV from BMS, respectively. The upper limit of two- sided 95% confidence intervals (CI) (equivalent to one-sided 97.5% CIs) for the difference between the treatment groups was ... See full document
21
An evaluation of the accuracy of the ORange<sup>®</sup> (Gen II) by comparing it to the IOLMaster<sup>®</sup> in the prediction of postoperative refraction
... The predicted postoperative spherical equivalent (SE) refractions from the IOLMaster were recorded. Since only the SE was used in the IOLMaster as the refractive data, the vecto[r] ... See full document
15
An update on the use of Atripla<sup>®</sup> in the treatment of HIV in the United States
... whether as part of Atripla or prescribed as part of a different CART regimen, allows potent combination therapy against hepatitis B as well as serving as the dual NRTI agent for HIV treatment. However, efavirenz ... See full document
8
The NordiNet<sup>®</sup> International Outcome Study and NovoNet<sup>®</sup> ANSWER Program<sup>®</sup>: rationale, design, and methodology of two international pharmacoepidemiological registry-based studies monitoring long-term clinical and safety outcomes of growth hormone therapy (Norditropin<sup>®</sup>)
... Cost-effectiveness data, increasingly required by pre- scribers and authorities, can be derived from the databases, which offer current data on GH treatment outcomes across a heterogeneous patient population. ... See full document
9
An update on TroVax<sup>®</sup> for the treatment of progressive castration-resistant prostate cancer
... Allogeneic whole cell vaccines have also been studied in CRPC and offer the advantage of not needing to define spe- cific antigens for vaccination. The GVAX platform utilizes irradiated allogeneic whole tumor cells ... See full document
15
Treatment of confirmed B12 deficiency in hemodialysis patients improves Epogen<sup>®</sup> requirements
... Our study showed a reduction in erythropoietin alpha dosing with B12 in the patients we determined to be deficient. Importantly, there were no side effects or toxicities associated with the vitamin B12 injections aside ... See full document
7
A novel system, TearCare<sup>®</sup>, for the treatment of the signs and symptoms of dry eye disease
... DED treatment and the recognized shortcomings in the use of at-home WCs as a long-term therapy to relieve the signs and symptoms of DED, including persistence, labor intensity, variability, poor ergonomics, heat ... See full document
14
Central aortic blood pressure and augmentation index: comparison between Vasotens<sup>®</sup> and SphygmoCor<sup>®</sup> technology
... Central aortic systolic blood pressure (aSBP) and augmen- tation index (aAIx) were obtained by means of applanation tonometry and the oscillometric method was compared.. Results: aSBP [r] ... See full document
5
An echo to Choosing Wisely<sup>®</sup> in Switzerland
... In May 2016, inspired by the US Choosing Wisely campaign, the Swiss Society of General Internal Medicine (SSGIM) released a list of five treatments or diagnostic tests relevant to the[r] ... See full document
9
Aterofisiol<sup>®</sup> in carotid plaque evolution
... one tablet of Aterofisiol every 24 hours or one tablet of Cardioaspirin + one tablet of placebo every 24 hours. Each treatment was started 30 days before the surgery and was stopped 5 days before the surgery. The ... See full document
17
Comparison of ultra-widefield fluorescein angiography with the Heidelberg Spectralis<sup>®</sup> noncontact ultra-widefield module versus the Optos<sup>®</sup> Optomap<sup>®</sup>
... Neither the authors nor the Weill Cornell Medical College have any direct or indirect financial interest in any manu- facturer of ultra-widefield imaging devices. No funding of any kind from any company was received to ... See full document
14
Radiesse<sup>®</sup>: a novel rejuvenation treatment for the upper arms
... This prospective, open-label study enrolled 30 women seek- ing improvement in the esthetic appearance of their upper arms. Eligible subjects were aged 45 − 65 years old, expressed a desire and willingness for the ... See full document
9
Related subjects